9.94 stock price up
Change
+ 0.14 (1.42%)
Volume
7,300
Exchange
NASDAQ
2:04 PM ET on Oct 21, 2014
Delayed at least 20 minutes.
Provided by eSignal.
3.61 stock price up
Change
+ 0.01 (0.33%)
Volume
47,134
Exchange
TASE
2:24 PM IT on Oct 21, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Oct 1, 2014
IntelGenx and RedHill Biopharma Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R)

Oct 1, 2014
RedHill Biopharma and IntelGenx Submit European Marketing Authorization Application for Migraine Drug RIZAPORT(R) (formerly RHB-103)

Sep 16, 2014
RedHill Biopharma to Present at the 14th Annual Biotech In Europe Forum for Global Partnering & Investment

View all »Upcoming Events & Presentations

Nov 3, 2014 - Nov 5, 2014
Bio-Europe 20th Annual International Partnering Conference
Portalhaus Messe Frankfurt, Germany

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com